Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. AAPL
6. RTB
7. ONON
8. AZN
9. SPCX
10. TRMD

Go back to Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026
(NASDAQ: QTTB) Delayed: 10.54 -0.32 (2.95%)
Previous Close $10.86    52 Week High $ 
Open $10.84    52 Week Low $ 
Day High $10.97    P/E N/A 
Day Low $10.46    EPS $ 
Volume 972,339